In November 2009, ASCO and the Oncology Nursing Society (ONS) jointly published a set of 31 voluntary chemotherapy safety standards for adult patients with cancer, as the end result of a highly ...

Objectives: To determine patient preferences and cost differences between home-based and hospital-based chemotherapy. Design: Randomised crossover trial. Setting: A tertiary cancer hospital in ...

The following represents disclosure information provided by author of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...

What is the closed-loop drug delivery system you are developing for chemotherapy? We are designing a system that is able to keep the concentration of a drug near its target concentration in the blood ...

Experts agree that combination approaches, which may or may not include chemotherapy, will drive improved patient outcomes in ...

Results from a global phase 3 clinical trial led by investigators at Mass General Brigham show that the medication romiplostim can effectively prevent chemotherapy from destroying platelet-producing ...

Sacubitril-valsartan, a common drug combination for heart failure, cuts the risk for cardiomyopathy after chemotherapy in patients who received anthracycline drugs by 77% in the first randomized ...

A new study published in JCO Precision Oncology has identified a relatively simple method to predict the cancer patients most likely to develop severe toxicities from chemotherapy. If doctors can ...